Cargando…
COVID-19 and the lungs: A review
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) attacks pulmonary alveolar cells via angiotensin-converting enzyme 2 (ACE2) receptors and causes pulmonary infections that result in coronavirus disease (COVID-19), inducing immune responses that can result in severe pneumonia. We reviewed...
Autores principales: | Su, Wen-Lin, Lu, Kuo-Cheng, Chan, Chih-Yu, Chao, You-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486577/ https://www.ncbi.nlm.nih.gov/pubmed/34700289 http://dx.doi.org/10.1016/j.jiph.2021.09.024 |
Ejemplares similares
-
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
por: Ho, Ping, et al.
Publicado: (2021) -
COVID-19 Associated with Cryptococcosis: A New Challenge during the Pandemic
por: Chan, Khee-Siang, et al.
Publicado: (2022) -
Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
por: Liao, Yu-Huang, et al.
Publicado: (2020) -
Immunological map in COVID-19
por: Li, Chung-Hsiang, et al.
Publicado: (2021) -
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review
por: Hou, Yi-Chou, et al.
Publicado: (2021)